Tacit Therapeutics

Developer of RNA trans-splicing therapies for genetic and brain diseases

placeSan Francisco, California, United States calendar_todayFounded 2021 language tacittx.com

Innovation

7 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace accelerating. Cited 143 times.

YearFilings
20235
20243
20257
20262

Investor mix

3 investors on record; lead investors include KdT Ventures.

Investor typeCountShare
Venture capital3100%
Coming soon